Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in 2019 in Wuhan, the capital of Hubei, China, and has since spread globally, resulting in the 2019–20 coronavirus pandemic. Common symptoms include fever, cough, and shortness of breath. Muscle pain, sputum production, diarrhea, and sore throat are less common. While the majority of cases result in mild symptoms, some progress to pneumonia and multi-organ failure. As of 25 March 2020, the rate of deaths per number of diagnosed cases is 4.5 percent; however, it ranges from 0.2 percent to 15 percent, according to age group and other health problems. The fatality rate varies widely from place to place and over time due to variation in how broadly a population is tested, and due to variations in availability of sufficient healthcare facilities and personnel.

This portal is used to evaluate the effectiveness of the compounds against all the Covid 27 protein structures available online in Modeled as well as the Experimentally evaluated the three-dimensional structure of proteins. This Database is still in the growing stage. The newer proteins will be entered as the research is progressed worldwide.The further evaluation of these results may be helpful to understand the clinical as well as the physiological effect of these drugs. Currently, it includes the drugs lesser than molecular weight of the 700.

Join this Crowd Sourcing effort initiated by the Bioinformatics Lab & Super-computing facility, Department of Bio-sciences, Veer Narmad South Gujarat University.